Potential Tariff Bites Into Becton Dickinson 2025 Profit Outlook, Company Will Invest $2.5 Billion To Boost US Manufacturing
benzinga.com/general/health-care/25/05/45140102/potential-tariff-bites-into-becton-dickinson-2025-profit-outlook-company-will-invest-2-5-bill
Becton, Dickinson, and Company (NYSE:BDX) lowered its fiscal year 2025 guidance and provided an estimated tariff impact on Thursday.
The medical device giant reported adjusted earnings per share of $3.35, up from $3.17 reported a year ago, beating the consensus of $3.28.
The company…
This story appeared on benzinga.com, 2025-05-01 15:03:24.